Developmental reprogramming of rat GLUT5 requires glucocorticoid receptor translocation to the nucleus

Journal of Physiology

Volumn 586, Issue 15, 2008, Pages 3657-3673

  Douard, Véronique ^a   Choi, Hye In ^a   Elshenawy, Summer ^a   Lagunoff, David ^b   Ferraris, Ronaldo P ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; DEXAMETHASONE; FRUCTOSE; GLUCOCORTICOID RECEPTOR; GLUCOSE TRANSPORTER 5; MESSENGER RNA; MIFEPRISTONE; PROGESTERONE; ARGINASE; ARGINASE 2; GLUCOSE 6 PHOSPHATASE; MINERALOCORTICOID RECEPTOR; PREGNANE X RECEPTOR; PROGESTERONE RECEPTOR; SODIUM GLUCOSE COTRANSPORTER 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; EXPERIMENTAL RAT; FRUCTOSE METABOLISM; GENE EXPRESSION REGULATION; GENE TARGETING; GENE TRANSLOCATION; GLUCOSE TRANSPORT SYSTEM; INTESTINE CELL; MATURATION; NONHUMAN; NUCLEAR REPROGRAMMING; NUCLEOTIDE SEQUENCE; NUTRIENT UPTAKE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL CELL; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GENOMICS; GROWTH RATE; MOLECULAR DYNAMICS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN TRANSPORT;

ACTIVE TRANSPORT, CELL NUCLEUS; AGING; ANIMALS; DEXAMETHASONE; FRUCTOSE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUCOSE TRANSPORTER TYPE 5; MIFEPRISTONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID;

EID: 48549088788     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2008.155226     Document Type: Article

References (55)

1. Agbemafle BM, Oesterreicher TJ, Shaw CA & Henning SJ (2005). Immediate early genes of glucocorticoid action on the developing intestine. Am J Physiol Gastrointest Liver Physiol 288, G897-G906.
2. Arima K, Hines ER, Kiela PR, Drees JB, Collins JF & Ghishan FK (2002). Glucocorticoid regulation and glycosylation of mouse intestinal type IIb Na-P (i) cotransporter during ontogeny. Am J Physiol Gastrointest Liver Physiol 283, G426-G434.
3. Ballard PL & Ballard RA (1995). Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 173, 254-262.
4. Blumberg B, Sabbagh W Jr, Juguilon H, Bolado J Jr, van Meter CM, Ong ES & Evans RM (1998). SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev 12, 3195-3205.
5. Boivin MA, Ye D, Kennedy JC, Al-Sadi R, Shepela C & Ma TY (2007). Mechanism of glucocorticoid regulation of the intestinal tight junction barrier. Am J Physiol Gastrointest Liver Physiol 292, G590-G598.
6. +-dependent glucose absorption and increases GLUT2 expression in the rat jejunal brush-border membrane. Am J Physiol Regul Integr Comp Physiol 292, R862-R867.
7. Burant CF, Takeda J, Brot-Laroche E, Bell GI & Davidson (1992). Fructose transporter in human spermatozoa and small intestine is GLUT5. J Biol Chem 267, 14523-14526.
8. Cui XL, Schlesier AM, Fisher EL, Cerqueira C & Ferraris RP (2005). Fructose-induced increases in neonatal rat intestinal fructose transport involve the PI3-kinase/Akt signaling pathway. Am J Physiol Gastrointest Liver Physiol 288, G1310-G1320.
9. Cui XL, Soteropoulos P, Tolias P & Ferraris RP (2004). Fructose-responsive genes in the small intestine of neonatal rats. Physiol Genomics 18, 206-217.
10. Dean DM & Sanders MM (1996). Ten years after: Reclassification of steroid-responsive genes. Mol Endocrinol 10, 1489-1495.
11. Douard V, Cui XL, Soteropoulos P & Ferraris RP (2008). Dexamethasone sensitizes the neonatal intestine to fructose induction of intestinal fructose transporter (Slc2A5) function. Endocrinology 149, 409-423.
12. Ferraris RP, Yasharpour S, Lloyd KC, Mirzayan R & Diamond JM (1990). Luminal glucose concentrations in the gut under normal conditions. Am J Physiol Gastrointest Liver Physiol 259, G822-G837.
13. Flynn NE, Meininger CJ, Kelly K, Ing NH, Morris SM Jr & Wu G (1999). Glucocorticoids mediate the enhanced expression of intestinal type II arginase and argininosuccinate lyase in postweaning pigs. J Nutr 129, 799-803.
14. Galand G (1989). Brush border membrane sucrase-isomaltase, maltase-glucoamylase and trehalase in mammals. Comparative development, effects of glucocorticoids, molecular mechanisms, and phylogenetic implications. Comp Biochem Physiol B 94, 1-11.
15. Gouyon F, Caillaud L, Carriere V, Klein C, Dalet V, Citadelle D, Kellett GL, Thorens B, Leturque A & Brot-Laroche E (2003). Simple-sugar meals target GLUT2 at enterocyte apical membranes to improve sugar absorption: A study in GLUT2-null mice. J Physiol 552, 823-832.
16. Gromova LV, Grefner NM, Gruzdkov AA & Komissarchik I (2006). [The role of facilitated diffusion in glucose transport across the apical membrane of enterocytes]. Ross Fiziol Zh Im I M Sechenova 92, 362-373.
17. Gross LS, Li L, Ford ES & Liu S (2004). Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: An ecologic assessment. Am J Clin Nutr 79, 774-779.
18. Harvey BJ, Alzamora R, Healy V, Renard C & Doolan CM (2002). Rapid responses to steroid hormones: From frog skin to human colon. A homage to Hans Ussing. Biochim Biophys Acta 1566, 116-128.
19. Henning S (1987). Functional development of gastrointestinal tract. In Physiology of The Gastrointestinal Tract, 2nd edn, ed. Johnson LR. Raven Press, New York.
20. Honma K, Mochizuki K & Goda T (2007). Carbohydrate/fat ratio in the diet alters histone acetylation on the sucrase-isomaltase gene and its expression in mouse small intestine. Biochem Biophys Res Commun 357, 1124-1129.
21. Ing NH (2005). Steroid hormones regulate gene expression posttranscriptionally by altering the stabilities of messenger RNAs. Biol Reprod 72, 1290-1296.
22. Jenkins BD, Pullen CB & Darimont BD (2001). Novel glucocorticoid receptor coactivator effector mechanisms. Trends Endocrinol Metab 12, 122-126.
23. Jiang L, David ES, Espina N & Ferraris RP (2001). GLUT-5 expression in neonatal rats: Crypt-villus location and age-dependent regulation. Am J Physiol Gastrointest Liver Physiol 281, G666-G674.
24. Jiang L & Ferraris RP (2001). Developmental reprogramming of rat GLUT-5 requires de novo mRNA and protein synthesis. Am J Physiol Gastrointest Liver Physiol 280, G113-G120.
25. Karasov W & Diamond J (1983). A simple method for measuring intestinal solute uptake in vitro. J Comp Physiol B 152, 105-116.
26. Kassel O & Herrlich P (2007). Crosstalk between the glucocorticoid receptor and other transcription factors: Molecular aspects. Mol Cell Endocrinol 275, 13-29.
27. Kirchner S, Kwon E, Muduli A, Cerqueira C, Cui XL & Ferraris RP (2006). Vanadate but not tungstate prevents the fructose-induced increase in GLUT5 expression and fructose uptake by neonatal rat intestine. J Nutr 136, 2308-2313.
28. Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, McKee DD, Oliver BB, Willson TM, Zetterstrom RH, Perlmann T & Lehmann JM (1998). An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92, 73-82.
29. Lebenthal A & Lebenthal E (1999). The ontogeny of the small intestinal epithelium. JPEN J Parenter Enteral Nutr 23, S3-S6.
30. Lowenberg M, Stahn C, Hommes DW & Buttgereit F (2007). Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids 73, 1029-1025.
31. Lu NZ & Cidlowski JA (2006). Glucocorticoid receptor isoforms generate transcription specificity. Trends Cell Biol 16, 301-307.
32. Ludwig DS, Peterson KE & Gortmaker SL (2001). Relation between consumption of sugar-sweetened drinks and childhood obesity: A prospective, observational analysis. Lancet 357, 505-508.
33. Ma K, Mallidis C, Bhasin S, Mahabadi V, Artaza J, Gonzalez-Cadavid N, Arias J & Salehian B (2003). Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab 285, E363-E371.
34. Manolescu AR, Witkowska K, Kinnaird A, Cessford T & Cheeseman C (2007). Facilitated hexose transporters: New perspectives on form and function. Physiology (Bethesda) 22, 234-240.
35. Oesterreicher TJ & Henning SJ (2004). Rapid induction of GATA transcription factors in developing mouse intestine following glucocorticoid administration. Am J Physiol Gastrointest Liver Physiol 286, G947-G953.
36. Ogle TF & Beyer BK (1982). Steroid-binding specificity of the progesterone receptor from rat placenta. J Steroid Biochem 16, 147-150.
37. Petersen YM, Hartmann B, Holst JJ, Le Huerou-Luron I, Bjornvad CR & Sangild PT (2003). Introduction of enteral food increases plasma GLP-2 and decreases GLP-2 receptor mRNA abundance during pig development. J Nutr 133, 1781-1786.
38. Putnam J, Allshouse J & Kantor LS (2002). U.S. per capita food supply trends: More calories, refined carbohydrates, and fats. Food Rev 25, 2-15.
39. Reddy KV, Bhattacharjee G, Schabbauer G, Hollis A, Kempf K, Tencati M, O'Connell M, Guha M & Mackman N (2004). Dexamethasone enhances LPS induction of tissue factor expression in human monocytic cells by increasing tissue factor mRNA stability. J Leukoc Biol 76, 145-151.
40. Rogerson FM, Yao YZ, Smith BJ, Dimopoulos N & Fuller PJ (2003). Determinants of spironolactone binding specificity in the mineralocorticoid receptor. J Mol Endocrinol 31, 573-582.
41. Rogerson FM, Yao Y, Smith BJ & Fuller PJ (2004). Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptor. Clin Exp Pharmacol Physiol 31, 704-709.
42. Schaaf MJ & Cidlowski JA (2002). Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol 83, 37-48.
43. Schoonen WG, Deckers GH, de Gooijer ME, de Ries R & Kloosterboer HJ (2000). Hormonal properties of norethisterone, 7α-methyl-norethisterone and their derivatives. J Steroid Biochem Mol Biol 74, 213-222.
44. Sheppard KE (2002). Nuclear receptors. II. Intestinal corticosteroid receptors. Am J Physiol Gastrointest Liver Physiol 282, G742-G746.
45. Shneider BL (1998). A new era in bile acid transport pathophysiology. J Pediatr Gastroenterol Nutr 26, 236-237.
46. Sitruk-Ware R, Bossemeyer R & Bouchard P (2007). Preclinical and clinical properties of trimegestone: A potent and selective progestin. Gynecol Endocrinol 23, 310-319.
47. Solomon NS, Gartner H, Oesterreicher TJ & Henning SJ (2001). Development of glucocorticoid-responsiveness in mouse intestine. Pediatr Res 49, 782-788.
48. Takabe S, Mochizuki K & Goda T (2007). The effects of dephosphorylation signal on glucocorticoid hormone-mediating GLUT5 expression in intestinal cells. FASEB J 21, 839.3. Experimental Biology 2007 Meeting Abstract.
49. Tasker JG, Di S & Malcher-Lopes R (2006). Minireview: Rapid glucocorticoid signaling via membrane-associated receptors. Endocrinology 147, 5549-5556.
50. Trotter KW & Archer TK (2007). Nuclear receptors and chromatin remodeling machinery. Mol Cell Endocrinol 265-266, 162-167.
51. Tsai MJ & O'Malley BW (1994). Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63, 451-486.
52. Wright EM, Hirayama BA & Loo DF (2007). Active sugar transport in health and disease. J Intern Med 261, 32-43.
53. Wu CW, Wang SR, Chien SL, Yeh TH, Lian SL, Shimizu N, Lui WY, P'Eng FK & Chi CW (1992). Regulation of arginase production by glucocorticoid in three human gastric cancer cell lines. Life Sci 51, 1355-1361.
54. 3. Am J Physiol Cell Physiol 282, C487-C493.
55. Zhang H, LeCulyse E, Liu L, Hu M, Matoney L, Zhu W & Yan B (1999). Rat pregnane X receptor: Molecular cloning, tissue distribution, and xenobiotic regulation. Arch Biochem Biophys 368, 14-22.